NCT05892146View on ClinicalTrials.gov

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chemotherapeutic ToxicityCardiotoxicityHeart FailureBreast CancerLymphoma
Interventions
DRUG

Prevention therapy

Sacubitril/Valsartan (25/80) mg twice a day for 1 year

DRUG

Rescue therapy

Sacubitril/Valsartan (25/80) mg twice a day for 1 year

Trial Locations (1)

Unknown

RECRUITING

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER